Showing 118 results
May 2020
-
Media Release
Novartis, Philippine Neurological Association hold virtual media briefing on easing and preventing migraine amid COVID-19 pandemic
Stress and anxiety induced by the COVID-19 pandemic are impacting migraine sufferers around the world. Fortunately, there are effective ways to ease symptoms and prevent migraine attacks, as well… -
Media Release
COVID-19 response in the Philippines: Novartis and Sandoz contributions
Novartis Healthcare Philippines is taking concrete steps to help ensure sustained supply of essential life-saving medicines to patients and support the country's COVID-19 response led by the… -
Media Release
Novartis donates PPEs and medicines to support Philippine response to COVID-19 pandemic
Novartis Healthcare Philippines is taking concrete steps to help ensure sustained supply of essential life-saving medicines to patients and support the country's COVID-19 response led by the…
September 2019
-
Media Release
Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with vildagliptin and metformin
Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes patients 1,2 The landmark VERIFY study is the first to… -
Media Release
Novartis supports global partnership to stop leprosy transmission
The Novartis Foundation and Novartis Healthcare Philippines joined key stakeholders from around the world in pledging to foster a global partnership to stop leprosy. The major leprosy control…